Arabinofuranosylcytosine
Category
Arabinofuranosylcytosine Brand names, Arabinofuranosylcytosine Analogs
Arabinofuranosylcytosine Brand Names Mixture
No information avaliable
Arabinofuranosylcytosine Chemical_Formula
C9H13N3O5
Arabinofuranosylcytosine RX_link
http://www.rxlist.com/cgi/generic3/cytarabine.htm
Arabinofuranosylcytosine fda sheet
Arabinofuranosylcytosine msds (material safety sheet)
Arabinofuranosylcytosine Synthesis Reference
Krenitski, et al; Carbohydr.Res.; 97, 139-146(1981)
Arabinofuranosylcytosine Molecular Weight
243.217 g/mol
Arabinofuranosylcytosine Melting Point
212-213oC
Arabinofuranosylcytosine H2O Solubility
Freely soluble
Arabinofuranosylcytosine State
Solid
Arabinofuranosylcytosine LogP
-2.712
Arabinofuranosylcytosine Dosage Forms
Injectable solution
Arabinofuranosylcytosine Indication
For the treatment of acute non-lymphocytic leukemia, acute lymphocytic leukemia and blast phase of chronic myelocytic leukemia.
Arabinofuranosylcytosine Pharmacology
Cytarabine is an antineoplastic anti-metabolite used in the treatment of several forms of leukemia including acute myelogenous leukemia and meningeal leukemia. Anti-metabolites masquerade as purine or pyrimidine - which become the building blocks of DNA. They prevent these substances becoming incorporated in to DNA during the "S" phase (of the cell cycle), stopping normal development and division. Cytarabine is metabolized intracellularly into its active triphosphate form (cytosine arabinoside triphosphate). This metabolite then damages DNA by multiple mechanisms, including the inhibition of alpha-DNA polymerase, inhibition of DNA repair through an effect on beta-DNA polymerase, and incorporation into DNA. The latter mechanism is probably the most important. Cytotoxicity is highly specific for the S phase of the cell cycle.
Arabinofuranosylcytosine Absorption
Less than 20% of the orally administered dose is absorbed from the gastrointestinal tract.
Arabinofuranosylcytosine Toxicity
Cytarabine syndrome may develop - it is characterized by fever, myalgia, bone pain, occasionally chest pain, maculopapular rash, conjunctivitis, and malaise.
Arabinofuranosylcytosine Patient Information
This medicine is a type of chemotherapy for treating cancers of the
blood and certain other cancers. This medicine interfers with the
way cancer cells grow, Take your doses on a regular scheduled time
and DO NOT take this medicine more often than directed by your health
care provider. Finish the full course prescribed by your health care
provider. DO NOT stop taking this medicine unless diredted to do so
by your health care provider. While taking this medicine, you make
get infection more easily. Call your doctor if you get a fever, chills,
or sore throat. Drink plenty of water with this medicine.
Arabinofuranosylcytosine Organisms Affected
Humans and other mammals